🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Systemic Treatments for Alopecia Areata Registry

Recruitingn/aAges 16 Years - anyAllErasmus Medical Center
NCT06283316 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A multicenter prospective registry (STA2R) is conducted to assess systemic treatments for alopecia areata, focusing on effectiveness, safety, and long-term outcomes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosed with alopecia areata; * Starting/using a systemic treatment for alopecia areata; * Informed consent for registry participation obtained from patient and/or caretaker. Exclusion Criteria: * Not sufficiently capable of understanding the Dutch language; * Not willing to participate.
💊

What it tests

  • Not listed
📍

Where

1 site
Erasmus University Medical Center
Rotterdam, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy